In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Tackling cardiovascular diseases with a new generation of polypills
Session

Event : ESC Congress 2020

Topic : Epidemiology

  • Session type : Industry Q&A session
  • Date : 31 August 2020
  • Time : 12:45 - 13:45
  • Sponsored by SERVIER

This content is currently on FREE ACCESS

 

5 presentations in this session

Introduction.

Event : ESC Congress 2020

  • Session : Tackling cardiovascular diseases with a new generation of polypills
  • Speaker : C Vlachopoulos (Athens,GR)
  • Sponsored by SERVIER

Benefits of controlling both blood pressure and LDL-cholesterol in terms of cardiovascular protection.

Event : ESC Congress 2020

  • Session : Tackling cardiovascular diseases with a new generation of polypills
  • Speaker : B Williams (London,GB)
  • Sponsored by SERVIER

From pathophysiology to clinical benefits: what new combinations of a statin and antihypertensive drugs can provide.

Event : ESC Congress 2020

  • Session : Tackling cardiovascular diseases with a new generation of polypills
  • Speaker : C Borghi (Bologna,IT)
  • Sponsored by SERVIER

Questions and Answers.

Event : ESC Congress 2020

  • Session : Tackling cardiovascular diseases with a new generation of polypills
  • Sponsored by SERVIER

Conclusion.

Event : ESC Congress 2020

  • Session : Tackling cardiovascular diseases with a new generation of polypills
  • Speaker : C Vlachopoulos (Athens,GR)
  • Sponsored by SERVIER

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are